Falcon Real World Evidence Registry

Launched by EXACT SCIENCES CORPORATION · Sep 5, 2024

Keywords

ClinConnect Summary

The Falcon Real World Evidence Registry is a study looking at how well the Exact Sciences Multicancer Early Detection (MCED) test can help find cancer early in patients. This registry is open for people aged 50 to 80 who are willing to take the MCED test and have follow-up imaging if needed. To participate, individuals must be able to give their consent and use technology to complete surveys online. It's important to note that people with certain types of cancer or those currently receiving cancer treatment are not eligible to join.

If you decide to participate in this study, you will receive the MCED test to check for signs of cancer, and if necessary, further imaging tests will be arranged. The goal of this trial is to gather real-world information about how effective the MCED test is in detecting different types of cancer early, which could potentially lead to better outcomes for patients. Your participation could help advance our understanding of cancer detection and improve future screening methods.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participant age at time of consent is between 50 and 80 years
• • Agree to receive the Exact Sciences MCED test and follow-up imaging
• • Willing and able to provide informed consent
• • Access to a suitable technology and willing to complete surveys electronically
• Exclusion Criteria:
• • Any invasive tumor (excluding non-melanoma skin cancers) or hematological malignancy in the previous three years or current suspicion of cancer and/or in active treatment (e.g., chemotherapy, radiation therapy, immunotherapy, and/or surgery